AtriCure, Inc.
NASDAQ: ATRC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Michael H. Carrel
- Employees
- 1,300
- Headquarters
- Mason, United States
- IPO year
- 2005
- Market cap
- $1.4B
- Website
- https://www.atricure.com
Loading ATRC…
Loading profile data…Frequently asked questions about ATRC
What does AtriCure, Inc. (ATRC) do?
AtriCure, Inc. creates, produces, and markets medical devices for the surgical treatment of cardiac tissue and intercostal nerves. Its market reach spans the United States, Europe, Asia, and other international territories. The company's product line features various ablation technologies. These include Isolator Synergy Clamps, which are single-...
Where does ATRC trade?
AtriCure, Inc. (ATRC) trades on the NASDAQ Global Market.
What sector is ATRC in?
AtriCure, Inc. (ATRC) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of AtriCure, Inc.?
Michael H. Carrel is the chief executive officer of AtriCure, Inc. (ATRC).
Where is AtriCure, Inc. headquartered?
AtriCure, Inc. is headquartered in United States.
Does ATRC pay a dividend?
AtriCure, Inc. (ATRC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ATRC go public?
AtriCure, Inc. (ATRC) completed its initial public offering in 2005.